此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

妇科颞下颌关节和骨盆之间的功能联系 (TMJ and Pelvis)

2026年9月20日 更新者:Małgorzata Wójcik、Poznan University of Physical Education

生殖器脱垂、子宫内膜异位症等妇科疾病妇女颞下颌关节与骨盆的功能关系

1 Recruitment. 2. Collection of written consents for the study. 3. Random assignment to groups with and without intervention. 4. Completion of questionnaires by study participants, postural pattern assessment, temporomandibular joint assessment, and platform assessment.

5. Performance of visceral therapy in the group with intervention, in the group without intervention placebo. Duration 5 weeks, treatment 1x per week at the same time of day and given day e.g. Mondays only.

6. Reassessment as in step 4. 7. Data collection, statistical analyses. 8. Interpretation of results for female participants. 9. Preparation of results for scientific publications.

研究概览

详细说明

Methods

After taking a detailed history, patients will be asked to:

  1. Completing: the SF-36 quality of life assessment questionnaire and Female Sexual Function Index assessment, and marking on a numerical scale their pain sensations for the temporomandibular joint and for the pelvis, World Health Organization Quality of Life BREF (WHOQOL-BREF).

    The SF-36 questionnaire, FSFI scale, World Health Organization Quality of Life BREF (WHOQOL-BREF) and numerical scale (assessing pain sensations for the temporomandibular joint and pelvic joint), will also be subjected to completion/checking after the completion of manual visceral treatments in groups with physiotherapy intervention for both conditions.

  2. Type of postural pattern according to Hall-Wernham-Littlejohn: type I - normal, type II - anterior pelvic tilt, type III - posterior pelvic tilt.

3 Pelvic type assessment: normal, high, low; pelvic type will be assessed in each patient and in groups with physiotherapeutic intervention for both conditions before and after manual visceral treatments.

4. Assessment of mobility in the temporomandibular joints in the sagittal plane CromWell digital caliper, and diagnosis using standardized protocols.

5. Postural assessment on the Posturomed Technomex platform and Podoscope Sensor Medica.

6. 6.Manual visceral treatments The treatments will be performed after the patient is qualified by the obstetrician-gynecologist specialist.

7. After performing techniques and placebo in both groups, filling out questionnaires again, measuring on the platform, pattern posture..

8. Statistical analysis: upon completion of the study, the collected quantitative and qualitative data will be subjected to statistical analysis. The choice of statistical tools will depend on the obtained probability distribution.

研究类型

介入性

注册 (估计的)

200

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习联系方式

研究联系人备份

  • 姓名:Anna M Paczkowska, Dr
  • 电话号码:12 +4861 285 40 31

学习地点

      • Poznan、波兰、61-871
        • 招聘中
        • Poznan University of Physical Education
        • 接触:

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年 至 60年 (成人)

接受健康志愿者

不

有资格学习的性别

女性

描述

Inclusion Criteria:

  1. Written consent to participate in the study.
  2. Female patients after surgical treatment with prolapse of reproductive organs and diagnosed endometriosis.

Exclusion Criteria:

  1. No written consent to participate in the study.
  2. Cancer.
  3. Injury to the temporomandibular joint and pelvis.
  4. Fibromyalgia.
  5. Rheumatic diseases.
  6. At each stage of the experiment if the patient decides that she does not want to participate she is excluded.

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:治疗
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:三倍

武器和干预

参与者组/臂
干预/治疗
实验性的:2 subgroups with wisceral therapy

A group of women with endometriosis and reproductive organ prolapse will be randomly assigned to the intervention will have visceral therapy performed, and the group without the intervention will have a placebo.

Visceral therapy will be performed manually by a physiotherapist, a detailed description of the techniques is above. Therapy will be in 2 subgroups with prolapse of the usual genitals and endometriosis.

安慰剂比较:2 subgroups with placebo (without intervention)

The group of women with endometriosis and reproduvtive organ prolapse without the intervention will have a placebo only hands held on the pelvis by a physiotherapist.

Placebo will be in 2 subgroups that will not have visceral therapy. The placebo will consist of the physiotherapist holding hands on the patient's pelvis.

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
NRS
大体时间:Time point one: before starting visceral therapy and placebo, 1 st week

Each patient will mark on the NRS scale the sensation of pain before the tests. Scale of 1-10, the higher the value the greater the pain experience.

Time point one: before starting visceral therapy and placebo, 1 st week
platforms
大体时间:Time point one: before starting visceral therapy and placebo,1 st week

Each patient will have a postural stability assessment prior to testing.No platform manufacturer provides standards. The platform is equipped with sensors - it collects the force of the feet and gives how the center of gravity is located, that is, the front-back, side-to-side tilts are given.

Time point one: before starting visceral therapy and placebo,1 st week
postural pattern by Halla-Wernhama-Littlejohna
大体时间:Time point one: before starting visceral therapy and placeb1 st weeko,

Before the test, each patient will have a postural pattern assessment. Evaluating the pattern of type 1 anterior tilt of the body, type 2 normal, type 3 posterior tilt.

Time point one: before starting visceral therapy and placeb1 st weeko,
pelvic type assessment
大体时间:Time point one: before starting visceral therapy and placebo,1 st week

Before the test, each patient will have a pelvic type assessment. High-assimilated type: hip plates above the L5 segment: overloaded type: hip plates below the L4 segment; normal type: hip plates at the level of the L4-L5 segment.

Time point one: before starting visceral therapy and placebo,1 st week
CromWell (measurement of oral dilation)
大体时间:Time point one: before starting visceral therapy and placebo,1 st week

Before the test, each patient will have their mouth opening measured with an electronic caliper.There are no standards given, it is a measurement of the dilation of the mouth.

Time point one: before starting visceral therapy and placebo,1 st week
standarised questonarie by Kulesa-Morawiecka et al.
大体时间:Time point one: before starting visceral therapy and placebo,1 st week

Each patient will complete a questionnaire on the evaluation of the temporomandibular joint. Scale of 0-10 points, 0 - means no strength of head and neck muscles, 10 - means strong tension of head and neck muscles.

Time point one: before starting visceral therapy and placebo,1 st week
According to the Polish version of the questionnaire, the highest point value, i.e. 171, indicates the lowest rank in the quality of life assessment, while the lowest point value indicates the highest level of quality of life.
大体时间:Time point one: before starting visceral therapy and placebo,1 st week

Each patient will complete a questionnaire on the evaluation of quality of life.Assessment: physical functioning, limitations due to physical health, pain perception, general sense of health, vitality, social functioning, emotional functioning and mental health.

Time point one: before starting visceral therapy and placebo,1 st week
Female Sexual Function Index. Score: a value of 26 points or less indicates the presence of significantly clinical sexual dysfunction.
大体时间:Time point one: before starting visceral therapy and placebo,1 st week

Each patient will complete a questionnaire.

Time point one: before starting visceral therapy and placebo,1 st week
visceral techniques and placebo
大体时间:1 st week, 2nd week, 3rd week,4th week, 5 week

The intervention group will have visceral therapy performed. The group without intervention will only have their hands held on the pelvis.

1 st week, 2nd week, 3rd week,4th week, 5 week
Masseter Muscles Tension
大体时间:2023-2025

The device was developed by the authors (PAT 2568 W.132167; patent W.132167). Its construction consists of two parallel beams between which strain gauges are placed to record their deformation under applied compressive force. The signal from the strain gauges was transmitted to a force meter, which displayed the result in mass units (kilograms). The recorded result was entered into an Excel spreadsheet. Measurements were performed under both eyes-open and eyes-closed conditions. Each measurement lasted 30 seconds. A 5-minute rest interval was applied between the eyes-open and eyes-closed measurements

2023-2025

次要结果测量

结果测量
措施说明
大体时间
NRS
大体时间:Time point two: after visceral therapy and placebo, 5th week

After 5 weeks, each patient will mark on the pain sensation scale. Scale of 1-10, the higher the value the greater the pain experience.

Time point two: after visceral therapy and placebo, 5th week
platforms
大体时间:Time point two: after visceral therapy and placebo, 5th week

After 5 weeks, each patient will have a postural stability assessment. No platform manufacturer provides standards. The platform is equipped with sensors - it collects the force of the feet and gives how the center of gravity is located, that is, the front-back, side-to-side tilts are given.

Time point two: after visceral therapy and placebo, 5th week
postural pattern by Halla-Wernhama-Littlejohna
大体时间:Time point two: after visceral therapy and placebo, 5th week

After 5 weeks, each patient will have a posture pattern assessment. Evaluating the pattern of type 1 anterior tilt of the body, type 2 normal, type 3 posterior tilt.

Time point two: after visceral therapy and placebo, 5th week
pelvic type assessment
大体时间:Time point two: after visceral therapy and placebo,5 th week

After 5 weeks, each patient will have a pelvic type assessment.High-assimilated type: hip plates above the L5 segment: overloaded type: hip plates below the L4 segment; normal type: hip plates at the level of the L4-L5 segment.

Time point two: after visceral therapy and placebo,5 th week
CromWell (measurement of oral dilation)
大体时间:Time point two: after visceral therapy and placebo, 5th week

After 5 weeks, each patient will have an evaluation of oral dilation with an electronic caliper.There are no standards given, it is a measurement of the dilation of the mouth.

Time point two: after visceral therapy and placebo, 5th week
standarised questonarie by Kulesa-Morawiecka et al.
大体时间:Time point two: after visceral therapy and placebo, 5th week

After 5 weeks, each patient will complete a temporomandibular joint evaluation questionnaire.Scale of 0-10 points, 0 - means no strength of head and neck muscles, 10 - means strong tension of head and neck muscles.

Time point two: after visceral therapy and placebo, 5th week
According to the Polish version of the questionnaire, the highest point value, i.e. 171, indicates the lowest rank in the quality of life assessment, while the lowest point value indicates the highest level of quality of life.
大体时间:Time point two: after visceral therapy and placebo, 5th week

After 5 weeks, each patient will complete a quality of life questionnaire. Assessment: physical functioning, limitations due to physical health, pain perception, general sense of health, vitality, social functioning, emotional functioning and mental health.

Time point two: after visceral therapy and placebo, 5th week
Female Sexual Function Index. Score: a value of 26 points or less indicates the presence of significantly clinical sexual dysfunction.
大体时间:Time point two: after visceral therapy and placebo, 5th week

After 5 weeks, each patient will complete a sexual satisfaction questionnaire

Time point two: after visceral therapy and placebo, 5th week
World Health Organization Quality of Life BREF (WHOQOL-BREF)
大体时间:Time point two: after visceral therapy and placebo, 5th week

After 5 weeks, each patient will complete a sexual satisfaction questionnaire

Time point two: after visceral therapy and placebo, 5th week

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2023年11月14日

初级完成 (估计的)

2026年9月30日

研究完成 (估计的)

2026年9月30日

研究注册日期

首次提交

2023年6月28日

首先提交符合 QC 标准的

2023年7月29日

首次发布 (实际的)

2023年8月7日

研究记录更新

最后更新发布 (实际的)

2026年9月24日

上次提交的符合 QC 标准的更新

2026年9月20日

最后验证

2026年9月1日

更多信息

与本研究相关的术语

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅